These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
397 related articles for article (PubMed ID: 7687134)
1. Use and toxicity of the colony-stimulating factors. Schriber JR; Negrin RS Drug Saf; 1993 Jun; 8(6):457-68. PubMed ID: 7687134 [TBL] [Abstract][Full Text] [Related]
2. Southwestern Internal Medicine Conference: clinical use of hematopoietic growth factors. Fleischman RA Am J Med Sci; 1993 Apr; 305(4):248-73. PubMed ID: 7682752 [TBL] [Abstract][Full Text] [Related]
3. [Hematopoietic growth factors]. Robak T Postepy Hig Med Dosw; 1991; 45(6):461-96. PubMed ID: 1726024 [TBL] [Abstract][Full Text] [Related]
6. Effect of stem cell factor (c-kit ligand), granulocyte-macrophage colony stimulating factor and interleukin 3 on hematopoietic progenitors in human long-term bone marrow cultures. Lemoli RM; Gulati SC Stem Cells; 1993 Sep; 11(5):435-44. PubMed ID: 7694721 [TBL] [Abstract][Full Text] [Related]
7. Granulocyte-macrophage colony-stimulating factor (GM-CSF) in the management of cancer. Fan D; O'Brian CA; Ioannides CG; Clyne RK In Vivo; 1991; 5(6):571-7. PubMed ID: 1810441 [TBL] [Abstract][Full Text] [Related]
8. Colony-stimulating factors: a new step in clinical practice. Part I. Nemunaitis J Ann Med; 1992 Dec; 24(6):439-44. PubMed ID: 1485935 [TBL] [Abstract][Full Text] [Related]
9. Hematopoietic colony-stimulating factors. Kaushansky K; Brown CB; Petersdorf S Biotechnology; 1991; 19():365-95. PubMed ID: 1723913 [TBL] [Abstract][Full Text] [Related]
10. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation. Lemoli RM; Fortuna A; Fogli M; Gherlinzoni F; Rosti G; Catani L; Gozzetti A; Miggiano MC; Tura S Exp Hematol; 1995 Dec; 23(14):1520-6. PubMed ID: 8542941 [TBL] [Abstract][Full Text] [Related]
11. Colony-stimulating factors for the management of neutropenia in cancer patients. Dale DC Drugs; 2002; 62 Suppl 1():1-15. PubMed ID: 12479591 [TBL] [Abstract][Full Text] [Related]
12. [Current status of the clinical application of hematopoietic growth factors in oncology]. Karthaus M; Ganser A Ther Umsch; 1996 Nov; 53(11):863-73. PubMed ID: 8984692 [TBL] [Abstract][Full Text] [Related]
17. The clinical use of colony stimulating factors. Moore MA Annu Rev Immunol; 1991; 9():159-91. PubMed ID: 1910675 [TBL] [Abstract][Full Text] [Related]
18. Future strategies in the control of myelosuppression: the use of colony-stimulating factors. Haeuber D Oncol Nurs Forum; 1991 Mar; 18(2 Suppl):16-21. PubMed ID: 2047296 [TBL] [Abstract][Full Text] [Related]
19. In vivo biology and therapeutic potential of hematopoietic growth factors and circulating progenitor cells. Herrmann F; Brugger W; Kanz L; Mertelsmann R Semin Oncol; 1992 Aug; 19(4):422-31. PubMed ID: 1380732 [No Abstract] [Full Text] [Related]
20. Recommendations on the use of colony-stimulating factors in children: conclusions of a European panel. Schaison G; Eden OB; Henze G; Kamps WA; Locatelli F; Ninane J; Ortega J; Riikonen P; Wagner HP Eur J Pediatr; 1998 Dec; 157(12):955-66. PubMed ID: 9877032 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]